An EMA committee has recommended approval of Alvotech’s AVT06, a biosimilar to Bayer’s blockbuster ophthalmology drug Eylea.

Harbour BioMed has entered a strategic partnership with Otsuka focusing on the development of HBM7020 for treating autoimmune ...

The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

Dedicated datasets highlight how social determinants of health can be used to improve overall standards of care.

Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

Revenue for Madrigal’s Rezdiffra, already approved in the US, is expected to skyrocket over the coming decade.

Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...

European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...